VRS
DAWN

Virginia Retirement Systems’s Day One Biopharmaceuticals DAWN Stock Holding History

Virginia Retirement Systems’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,700
Closed -$76K – 963
2025
Q2 		$76K Sell
11,700
-400
-3% -$2.75K ﹤0.01% 927
2025
Q1 		$96K Buy
+12,100
New +$130K ﹤0.01% 1002

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Virginia Retirement Systems's DAWN Position: Q3 2025 in Review

Virginia Retirement Systems sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 11,700 shares — an estimated $76K sold.

Virginia Retirement Systems first reported a position in DAWN in Q1 2025 and held it in 2 quarters. The position peaked at $96K in Q1 2025. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

  • Virginia Retirement Systems reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,700 Day One Biopharmaceuticals shares in Q3 2025, an estimated $76K.
  • Virginia Retirement Systems first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Virginia Retirement Systems's Day One Biopharmaceuticals position peaked at $96K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on Virginia Retirement Systems's 13F filing for Q3 2025, filed 20 Oct 2025.